COVID-19 testing has been limited by a global shortage of critical supplies(1). PerkinElmer is extending support to mitigate the issue by providing a live stream of RT-PCR test and automated RNA extraction equipment lead time for setting up labs to process 50,000 samples each day. The lead time will be updated regularly based on inventory and demand.

Contact Us To Overcome Your SARS-CoV-2 Challenges


We are here to help laboratories overcome their SARS-CoV-2 testing challenges so they can better address the world’s urgent public health concerns. We are working closely with laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and vaccine development solutions they need to rapidly respond to these challenges. Our top priority is to provide the technology and support to meet these needs.

We help labs:

  • Increase throughput
  • Improve accuracy
  • Increase efficiency
  • Enhance laboratory safety


PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 – EUA
The FDA EUA authorized PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV.

Simultaneous COVID-19, Flu, and RSV Test – CE-IVD
Detect and differentiate SARS-CoV-2, influenza A, influenza B, and RSV in a single sample with the CE-IVD marked PKamp Respiratory SARS-CoV-2 RT-PCR Panel. This workflow enables labs to conserve resources while testing a single sample for multiple pathogens.

PerkinElmer® New Coronavirus Nucleic Acid Detection Kit Authorized Under FDA EUA
The PerkinElmer® New Coronavirus Nucleic Acid Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in human oropharyngeal, nasopharyngeal, and anterior nasal swab samples from symptomatic individuals. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories.

COVID-19 Lab-In-A-Lab™ Testing Solution
Increase your SARS-CoV-2 testing capabilities with the COVID-19 Lab-In-A-Lab™ testing solution, a full-service turnkey testing option embedded in your CLIA certified lab.



Viral RNA Isolation
The PerkinElmer chemagic Viral DNA/ RNA 300 Kit H96 and the chemagic 360 instrument deliver fast, high throughput extraction of high-quality RNA for use with PCR-based detection of SARS-CoV-2. With this setup, RNA can be extracted from 96 samples per hour, producing high quality RNA.

Automation of RNA Isolation Setup and PCR Assay Setup
Specialized JANUS® G3 automated workstations are now available to optimize your SARS-CoV-2 testing workflow. With the ability to automate sample prep for RNA isolation and PCR setup these workstations are designed to be used with any SARS-CoV-2 viral extraction and detection assay chemistry.

Mobile Monitoring of SARS-CoV-2 Testing
PerkinElmer has coupled the new PKeye™ Mobile Operations Monitor with the JANUS® G3 Primary Sample reformatter and PCR liquid handler to enable your lab to increase the consistency and reliability of your automated SARS-CoV-2 detection workflow.

explorer™ Workstations for End-to-End SARS-CoV-2 Testing
PerkinElmer enables labs to maximize the efficiency of their SARS-CoV-2 RT-PCR and ELISA testing with scalable and modular explorer workstations and a reliable supply of reagents and consumables, ensuring they can meet their ever-changing testing needs.

NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2
The NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2 has been designed to detect all mutations associated with SARS-CoV-2, including those specific to the omicron variant, in a PCR-positive sample. With the incorporation of normalization beads, the NEXTFLEX® Variant-Seq™ SARS-CoV-2 v2 kit reduces turn-around time by up to three hours mostly due to eliminating the need for individual library quantification prior to the pooling step.

Simplify SARS-CoV-2 Variant Detection with Complete NGS Workflows
Complete NGS workflows enable effective and high-throughput tracking of mutational changes in the SARS-CoV-2 virus.


Fast & Sensitive Antigen Test – CE-IVD
Enable your POC testing with the PerkinElmer COVID-19 Antigen Test, a simple, rapid, and reliable lateral flow immunoassay test used to screen or diagnose COVID-19 in asymptomatic or symptomatic individuals.

Overview of SARS-CoV-2 Antibody Assays
Explore PerkinElmer’s immunoassays optimized for use with varied samples types, throughputs, run times, and targets.

PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit CE-IVD
The PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG kit delivers qualitative detection of human IgG antibodies against SARS-CoV-2 in dried blood spots, plasma, and serum to identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

PerkinElmer® SuperFlex™ Anti-SARS-CoV-2 IgG Kit CE-IVD
Achieve fast, hands-free anti-SARS-CoV-2 IgG antibody detection using direct chemiluminescence technology with the SuperFlex™ Anti-SARS-CoV-2 kit. Samples are run on the SuperFlex™ Chemiluminescent Immunoassay system, allowing hands-free analysis of up to 48 samples per hour to quickly identify recent or prior infections.

SuperFlex™ Chemiluminescent Immunoassay System CE-IVD
The SuperFlex™ Chemiluminescent Immunoassay system delivers fast, hands-free analysis of small biological molecules using labeled antibodies and antigens.

SARS-CoV-2 ELISA Test Systems from EUROIMMUN

Simplifying the Analysis of the SARS-CoV-2 Virus with NGS
PerkinElmer’s NGS workflows enable effective and high-throughput detection of the SARS-CoV-2 virus, surveillance and epidemiological studies, the tracking of mutational changes in the virus, unbiased pathogen discovery, and the analysis of potential susceptibility and human response to SARS-CoV-2 infection.


Real-time PCR Assay Antibody Assay Targeted Sequencing WGS/Shotgun Sequencing Expression Analysis
Detect active infections X
Detect virus X X X
Perform surveillance & epidemiology X X X
Detect patient immunity X
Speed & TAT X X
Track mutations X X
Discovery X X
Analyze human response to disease X X X
Contact Us To Overcome Your SARS-CoV-2 Challenges